-
Je něco špatně v tomto záznamu ?
Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice
S. Musilova, N. Modrackova, P. Hermanova, T. Hudcovic, R. Svejstil, V. Rada, V. Tejnecky, V. Bunesova,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
PubMed
28116928
DOI
10.3920/bm2016.0138
Knihovny.cz E-zdroje
- MeSH
- acetáty metabolismus MeSH
- Bifidobacterium longum subsp. infantis * MeSH
- císařský řez MeSH
- feces mikrobiologie MeSH
- gastrointestinální trakt mikrobiologie MeSH
- interleukin-10 biosyntéza MeSH
- interleukin-6 biosyntéza MeSH
- laktáty metabolismus MeSH
- lidé MeSH
- mateřské mléko chemie MeSH
- myši MeSH
- novorozenec MeSH
- oligosacharidy aplikace a dávkování MeSH
- prebiotika aplikace a dávkování MeSH
- probiotika aplikace a dávkování MeSH
- střevní mikroflóra účinky léků MeSH
- synbiotika aplikace a dávkování MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- novorozenec MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The mode of delivery plays a crucial role in infant gastrointestinal tract colonisation, which in the case of caesarean section is characterised by the presence of clostridia and low bifidobacterial counts. Gut colonisation can be modified by probiotics, prebiotics or synbiotics. Human milk oligosaccharides (HMOs) are infant prebiotics that show a bifidogenic effect. Moreover, genome sequencing of Bifidobacterium longum subsp. infantis within the infant microbiome revealed adaptations for milk utilisation. This study aimed to evaluate the synbiotic effect of B. longum subsp. infantis, HMOs and human milk (HM) both in vitro and in vivo (in a humanised mouse model) in the presence of faecal microbiota from infants born by caesarean section. The combination of B. longum and HMOs or HM reduced the clostridia and G-bacteria counts both in vitro and in vivo. The bifidobacterial population in vitro significantly increased and produce high concentrations of acetate and lactate. In vitro competition assays confirmed that the tested bifidobacterial strain is a potential probiotic for infants and, together with HMOs or HM, acts as a synbiotic. It is also able to inhibit potentially pathogenic bacteria. The synbiotic effects identified in vitro were not observed in vivo. However, there was a significant reduction in clostridia counts in both experimental animal groups (HMOs + B. longum and HM + B. longum), and a specific immune response via increased interleukin (IL)-10 and IL-6 production. Animal models do not perfectly mimic human conditions; however, they are essential for testing the safety of functional foods.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016791
- 003
- CZ-PrNML
- 005
- 20180521140158.0
- 007
- ta
- 008
- 180515s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3920/BM2016.0138 $2 doi
- 035 __
- $a (PubMed)28116928
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Musilova, S $u 1 Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, 165 21 Prague 6, Czech Republic.
- 245 10
- $a Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice / $c S. Musilova, N. Modrackova, P. Hermanova, T. Hudcovic, R. Svejstil, V. Rada, V. Tejnecky, V. Bunesova,
- 520 9_
- $a The mode of delivery plays a crucial role in infant gastrointestinal tract colonisation, which in the case of caesarean section is characterised by the presence of clostridia and low bifidobacterial counts. Gut colonisation can be modified by probiotics, prebiotics or synbiotics. Human milk oligosaccharides (HMOs) are infant prebiotics that show a bifidogenic effect. Moreover, genome sequencing of Bifidobacterium longum subsp. infantis within the infant microbiome revealed adaptations for milk utilisation. This study aimed to evaluate the synbiotic effect of B. longum subsp. infantis, HMOs and human milk (HM) both in vitro and in vivo (in a humanised mouse model) in the presence of faecal microbiota from infants born by caesarean section. The combination of B. longum and HMOs or HM reduced the clostridia and G-bacteria counts both in vitro and in vivo. The bifidobacterial population in vitro significantly increased and produce high concentrations of acetate and lactate. In vitro competition assays confirmed that the tested bifidobacterial strain is a potential probiotic for infants and, together with HMOs or HM, acts as a synbiotic. It is also able to inhibit potentially pathogenic bacteria. The synbiotic effects identified in vitro were not observed in vivo. However, there was a significant reduction in clostridia counts in both experimental animal groups (HMOs + B. longum and HM + B. longum), and a specific immune response via increased interleukin (IL)-10 and IL-6 production. Animal models do not perfectly mimic human conditions; however, they are essential for testing the safety of functional foods.
- 650 _2
- $a acetáty $x metabolismus $7 D000085
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a Bifidobacterium longum subsp. infantis $7 D000070236
- 650 _2
- $a císařský řez $7 D002585
- 650 _2
- $a feces $x mikrobiologie $7 D005243
- 650 _2
- $a střevní mikroflóra $x účinky léků $7 D000069196
- 650 _2
- $a gastrointestinální trakt $x mikrobiologie $7 D041981
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a interleukin-10 $x biosyntéza $7 D016753
- 650 _2
- $a interleukin-6 $x biosyntéza $7 D015850
- 650 _2
- $a laktáty $x metabolismus $7 D007773
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mateřské mléko $x chemie $7 D008895
- 650 _2
- $a oligosacharidy $x aplikace a dávkování $7 D009844
- 650 _2
- $a prebiotika $x aplikace a dávkování $7 D056692
- 650 _2
- $a probiotika $x aplikace a dávkování $7 D019936
- 650 _2
- $a synbiotika $x aplikace a dávkování $7 D058616
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Modrackova, N $u 1 Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, 165 21 Prague 6, Czech Republic.
- 700 1_
- $a Hermanova, P $u 2 Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, v.v.i., Doly 183, 549 22 Novy Hradek, Czech Republic.
- 700 1_
- $a Hudcovic, T $u 2 Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, v.v.i., Doly 183, 549 22 Novy Hradek, Czech Republic.
- 700 1_
- $a Svejstil, R $u 1 Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, 165 21 Prague 6, Czech Republic.
- 700 1_
- $a Rada, V $u 1 Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, 165 21 Prague 6, Czech Republic.
- 700 1_
- $a Tejnecky, V $u 3 Department of Soil Science and Soil Protection, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, 165 21 Prague 6, Czech Republic.
- 700 1_
- $a Bunesova, V $u 1 Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, 165 21 Prague 6, Czech Republic.
- 773 0_
- $w MED00187987 $t Beneficial microbes $x 1876-2891 $g Roč. 8, č. 2 (2017), s. 281-289
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28116928 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180521140340 $b ABA008
- 999 __
- $a ok $b bmc $g 1300415 $s 1013631
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 8 $c 2 $d 281-289 $e 20170124 $i 1876-2891 $m Beneficial microbes $n Benef Microbes $x MED00187987
- LZP __
- $a Pubmed-20180515